Tango Therapeutics, Inc. · NASDAQ:TNGX
TCG Crossover GP II, LLC's stake in Tango Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
TCG Crossover GP II, LLC's stake in Tango Therapeutics, Inc. fell to 4.60%, 7,839,709 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 7,839,709
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 4.60% | 7,839,709 |
| TCG Crossover Fund II, L.P. | 4.60% | 7,839,709 |
| Chen Yu | 4.60% | 7,839,709 |
Source
Download original · View original at SEC
Related
- Tango Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Feb 17, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 14, 2025
- Form 4 · Ketchum John B · Nov 19, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 16, 2026
- Form 4 · Crystal Adam · Nov 13, 2026
- Schedule 13G/A · FMR LLC · Nov 6, 2026
- Form 4 · Crystal Adam · Nov 4, 2026